What changed: KIT exon 11-mutant GIST

Cancer page →

Every dated change on the records linked to KIT exon 11-mutant GIST, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Milestone5This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-17This recordKIT exon 11-mutant GIST
Facts on this page last checked
When this page itself was last checked or edited.

2012 · 1

2012MilestoneImatinib
SSG XVIII: three years of adjuvant imatinib extends overall survival
A milestone in how this cancer is treated.

2009 · 1

2009MilestoneImatinib
ACOSOG Z9001: one year of adjuvant imatinib reduces recurrence
A milestone in how this cancer is treated.

2002 · 1

2002MilestoneImatinib
B2222 phase 2 and FDA approval of imatinib for metastatic GIST
A milestone in how this cancer is treated.

2001 · 1

2001MilestoneImatinib
First GIST patient treated with imatinib responds (Joensuu)
A milestone in how this cancer is treated.

1998 · 1

1998MilestoneKIT
Hirota identifies gain-of-function KIT mutations in GIST
A milestone in how this cancer is treated.